Nina Capital is a venture capital firm that focuses on investing in early-stage healthcare startups. The firm aims to support companies that are leveraging technology to create innovative solutions in the healthcare sector, with a particular interest in biotech, digital health, and medical devices. Nina Capital seeks to contribute to the improvement of health outcomes by backing visionary entrepreneurs and disruptive technologies.

Marta-Gaia Zanchi

Nina Capital

Medical Devices Venture is a holding company that develops a portfolio of investments in Med Tech start-ups. The aim is to combine the expertise of researchers in hospital and university settings with industrialization and commercialization capabilities.

Medical Devices Venture

We have a vision for the future in which data, computing, networks, and other digital and deep technologies deliver meaningful outcomes and insight for improving health and the provision of care. We believe the creation of new businesses is built on in-depth understanding of the complex network of healthcare system participants, and marrying that with meaningful engineering innovation, advanced data science, and information technology-enabled products and services. We look for and seed founders determined to effectively and efficiently serve these participants on the european continent and internationally. We are committed to addressing needs across the care continuum, healthcare systems, and all specialties. 

Replica Analytics

did you know?
our venture partners have collective decades of experience in leadership in some of the world's top medtech manufacturers, companies and institutions like Microsoft, Philips, Apple, NHS, Hewlett Packard Enterprise, Optum, Aetna, a CVS Health Company, Eagle Genomics or Bupa.

We are very proud to be collaborating with top venture partners based around the world. These outstanding professionals increase the capacities of our core team with their wide-ranging experience and networks.

Meet our venture partners:
💫  Rebecca Schechter 
💫 Helen Routh
💫 Anil Sethi
💫 Abel Ureta-Vidal
💫 Dr Hemal Desai

More info on our website: https://lnkd.in/d4knYqhQ 

#venturepartner #venturecapital #investment #healthtech #innovation #wearenina

Artificial intelligence and breast cancer: What's next?

https://lnkd.in/dDrEMrHA

Kheiron Medical #oncology #breastcancer #cancer #innovation #screening #wearenina

"No"
"No!"
"Sorry, no."
"I like you, but no."
"Not yet."
"No, thank you."
"Nope. Good luck!"
...

In the startup world, when you are fundraising, the "NO" responses come much more numerous than the "YES" responses, and to make matters worse, they come earlier. That's if you are lucky and no one is subjecting you to radio silence (a period when someone does not communicate despite having established a solid and promising communication channel).

Almost everyone is a champion at handling a "YES." We are all the worst versions of ourselves when we are rejected. When you open your inbox and see a "NO," don't hurry into making a mistake. 

Check your heart rate. Is it accelerating? Are the memories of all the hard work you put in to get this far causing distress? Do you feel heavy on your chest the task of breaking the disappointing news with your cofounders, employees, or Board of Directors?

If any of that is true, stop. Snooze the email until later. Wait to respond for one, three, or more days. Put a reminder on the calendar to respond in a week. When you're ready to respond using your heart and your brain, and not your stomach, go back to that "NO." If you see a learning opportunity, go after it politely. If not, say thanks (and mean it) and move on. 

What you are doing is special, and it is not obvious. Many people will make a mistake by turning you down. In fact, most will. That's okay. You don't need many people—just the few right ones.

Be kind and smart, always. If you can't be smart, at least be kind. The people you're speaking with may be genuinely your biggest fan club at the same time as they are saying "NO." And even if not, there are still people, even if they just made a mistake.

And remember, it's not supposed to be easy. Otherwise, it would not be special, and it would be quite obvious. Now, time to get ready for the next pitch.

#fundraising #wearenina Nina Capital 

NEWS

QuantHealth is one of Fast Company’s Most Innovative Companies in Europe, the Middle East, and Africa for 2024.

'This startup uses AI to simulate clinical trials and speed new drugs to market'

Read the feature in Fast Company:
https://lnkd.in/ekTMs_hj

Congrats Orr Inbar and team for this amazing recognition 

#healthtech #innovation #clinicaltrials #drugdiscovery #wearenina

Healee revolutionizes healthcare with AI for better patient experience

'The stark contrast between the user experience in sectors like banking, shopping, and travel compared to healthcare is strikingly evident. Healthcare often lags behind, offering a more cumbersome and less user-friendly experience. Addressing this gap, Healee, co-founded by Plamen Petrov, Ph.D., Hristo Kosev, and Josif Dishliev, is set on revolutionizing the healthcare landscape by integrating consumer-friendly experiences through AI technology that people have become accustomed to in other areas of their lives'.

Read more: 
https://lnkd.in/eZyjvfcj

#innovation #healthtech #patientexperience #AI #wearenina

Metric
Company Name	Nina Capital	Medical Devices Venture
Symbol
MSH ID	CAPITAL:NINA	COM:MEDICALDEVICESVENTURE
Market	PRIVATE	PRIVATE
Sector	Financial Services & Finance	Healthcare & Health Services
Industry	Venture Capital	Medical Devices
Country	ES	FR
Stage
Employee Count	34
Website	nina.capital	medicaldevicesventure.com
LinkedIn	ninacapital	medical-devices-venture
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	1.11K
Web Traffic Growth	-0.12
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

CAPITAL:NINA

Nina Capital

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue